Precigen (PGEN) EPS (Weighted Average and Diluted): 2012-2025
Historic EPS (Weighted Average and Diluted) for Precigen (PGEN) over the last 6 years, with Sep 2025 value amounting to -$1.06.
- Precigen's EPS (Weighted Average and Diluted) fell 1077.78% to -$1.06 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.39, marking a year-over-year decrease of 152.73%. This contributed to the annual value of -$0.47 for FY2024, which is 20.51% down from last year.
- According to the latest figures from Q3 2025, Precigen's EPS (Weighted Average and Diluted) is -$1.06, which was down 1,077.78% from -$0.09 recorded in Q2 2025.
- In the past 5 years, Precigen's EPS (Weighted Average and Diluted) ranged from a high of $0.44 in Q3 2022 and a low of -$1.06 during Q3 2025.
- Its 3-year average for EPS (Weighted Average and Diluted) is -$0.20, with a median of -$0.10 in 2024.
- As far as peak fluctuations go, Precigen's EPS (Weighted Average and Diluted) surged by 393.33% in 2022, and later plummeted by 1,077.78% in 2025.
- Precigen's EPS (Weighted Average and Diluted) (Quarterly) stood at -$0.13 in 2021, then grew by 15.38% to -$0.11 in 2022, then dropped by 18.18% to -$0.13 in 2023, then surged by 53.85% to -$0.06 in 2024, then tumbled by 1,077.78% to -$1.06 in 2025.
- Its last three reported values are -$1.06 in Q3 2025, -$0.09 for Q2 2025, and -$0.18 during Q1 2025.